Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
02/2012
02/02/2012WO2012015750A2 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies
02/02/2012WO2012015674A1 THERAPEUTIC USES OF AN FGFR1c ANTIBODY
02/02/2012WO2012014994A1 Naphthalene derivative
02/02/2012WO2012014993A1 Agent for increasing translation initiation factor or translation elongation factor, and use thereof for medical purposes
02/02/2012WO2012014805A1 Nitric oxide generation regulator
02/02/2012WO2012013750A1 Use of dronedarone for the preparation of a medicament for the hospitalization burden in patient with atrial fibrillation
02/02/2012WO2012013597A1 Substances and the use thereof for influencing natriuretic peptide receptors
02/02/2012WO2012013249A1 Dentin matrix protein 1 (dmp1) for use in pharmaceutical compositions
02/02/2012WO2012013118A1 Carvedilol sulfate crystals, preparation method thereof, and pharmaceutical use thereof
02/02/2012WO2012013111A1 Angiogenesis-inhibiting peptide and application thereof
02/02/2012WO2012013110A1 Polypeptide having angiogenesis-inhibiting activity
02/02/2012WO2012013088A1 Dronedarone solid dispersion and preparation method thereof
02/02/2012WO2012012870A1 Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complex
02/02/2012WO2012012843A1 Modulators of protease activated receptors
02/02/2012WO2011122899A3 Pharmaceutical composition for inhibiting platelet aggregation or for thrombolysis
02/02/2012WO2011102695A3 Composition for preventing or treating diseases caused by over-expression of lxrα, containing liquiritigenin or isoliquiritigenin as active ingredient
02/02/2012WO2011091065A8 Synthetic nanostructures including nucleic acids and/or other entities
02/02/2012US20120030779 Compositions and methods for detecting, treating, or preventing reductive stress
02/02/2012US20120029475 Drug Combinations Useful for Prevention of Restenosis
02/02/2012US20120029447 Transdermal pharmaceutical preparation and administration of tirofiban
02/02/2012US20120029416 Porous electroactive hydrogels and uses thereof
02/02/2012US20120029091 Method of controlling the release of an active ingredient from a dosage form
02/02/2012US20120029083 Polymorphic forms of aliskiren hemifumarate and process for preparation thereof
02/02/2012US20120029079 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
02/02/2012US20120029053 Short Interfering Ribonucleic Acid (siRNA) for Oral Administration
02/02/2012US20120029052 Short Interfering Ribonucleic Acid (siRNA) for Oral Administration
02/02/2012US20120029048 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies
02/02/2012US20120029029 Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta hsd1 modulators
02/02/2012US20120029026 Pyridine derivative
02/02/2012US20120029022 Potent Non-Urea Inhibitors Of Soluble Epoxide Hydrolase
02/02/2012US20120029016 Indoles Useful in the Treatment of Inflammation
02/02/2012US20120029011 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
02/02/2012US20120029007 Morphinan compounds
02/02/2012US20120029003 Galectin-3 and statin therapy
02/02/2012US20120029002 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases
02/02/2012US20120028995 Novel compounds for medical use as peptidase effectors
02/02/2012US20120028992 Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
02/02/2012US20120028989 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
02/02/2012US20120028986 2-heteroaryl-pyrrolo [3,4-c]pyrrole derivatives, and use thereof as scd inhibitors
02/02/2012US20120028983 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
02/02/2012US20120028982 2-amino-bicyclo[3.1.0]hexane-2, 6-dicarboxylic ester derivative
02/02/2012US20120028976 Pharmacokinetically-based dosing regiments of a thrombin receptor antagonist
02/02/2012US20120028971 Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof
02/02/2012US20120028970 Heteroarylthiomethyl pyridine derivative
02/02/2012US20120028967 Novel diaza-bicyclononyl-pyrimidinyl derivatives and their medical use
02/02/2012US20120028966 Protein kinase inhibitors
02/02/2012US20120028965 Compounds useful as protein kinase inhibitors
02/02/2012US20120028963 Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same
02/02/2012US20120028954 Substituted Pyridine, Pyridazine, Pyrazine And Pyrimidine Compounds And Methods For Using The Same
02/02/2012US20120028953 Azetidine Derivatives
02/02/2012US20120028950 Substituted heterocyclylbenzylpyrazoles and use thereof
02/02/2012US20120028941 Pharmaceutical Product Comprising a P38 Kinase Inhibitor and a Second Active Ingredient
02/02/2012US20120028939 Substituted naphthyridines and their use as medicaments
02/02/2012US20120028937 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
02/02/2012US20120028930 Flupirtine salts and polymorphs
02/02/2012US20120028926 Phosphate Management with Small Molecules
02/02/2012US20120028922 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
02/02/2012US20120028921 Methods and compositions using oxidized phospholipids
02/02/2012US20120028902 Peptide availability
02/02/2012US20120028899 Composition and process for synthesizing tense and relaxed state polymerized hemoglobin
02/02/2012US20120028897 Methods and compositions for the treatment of fluid retention disorders
02/02/2012US20120028896 Use of fibroblast growth factor fragments
02/02/2012US20120028894 Peptides, pharmaceutical compositions comprising same and uses thereof
02/02/2012US20120028888 Apj receptor compounds
02/02/2012US20120028881 Methods and reagents for diagnosing atheroma
02/02/2012US20120028880 Vegfr-1/nrp-1 targeting peptides
02/02/2012US20120027877 Nitric oxide generator and non-deliquescent tablet for use in same
02/02/2012US20120027871 Method of treatment based on polymorphisms of the kcnq1 gene
02/02/2012US20120027854 Pharmaceutical composition comprising ezetimibe and simvastatin
02/02/2012US20120027850 Compositions and Methods for Treatment of Aortic Fibrosis
02/02/2012US20120027849 Stable pharmaceutical composition for atherosclerosis
02/02/2012US20120027843 Hb-egf bound protein complex
02/02/2012US20120027834 Methods of treatment with syk inhibitors
02/02/2012US20120027807 Tissue engineered myocardium and methods of production and uses thereof
02/02/2012US20120027787 Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
02/02/2012US20120027781 Neuroprotective and neurorestorative method and compositions
02/02/2012US20120027777 Ljungan virus with improved replication characteristics
02/02/2012US20120027774 Metalloproteinase 9 binding proteins
02/02/2012US20120027744 Modified heparinase iii and methods of sequencing therewith
02/02/2012US20120027740 Method and means for producing tissues and tissues obtained
02/02/2012US20120027719 Polyester Based Degradable Materials and Implantable Biomedical Articles Formed Therefrom
02/02/2012US20120027687 Fatty acid protein kinase c activators and anticoagulant for the treatment of stroke
02/02/2012US20120027680 Oxime conjugates and methods for their formation and use
02/02/2012US20120024743 Transdermal pharmaceutical preparations
02/02/2012DE102010032482A1 New receptor agonist having renin-suppressing activity, antihypertrophic activity and influence of second messenger cyclic guanosine monophosphate during vasodilation, natriuresis and diuresis, useful to treat e.g. nephrotic syndrome
02/02/2012CA2806606A1 Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complex
02/02/2012CA2806341A1 Ampk-activating heterocyclic compounds and methods for using the same
02/02/2012CA2805766A1 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies
02/01/2012EP2412719A1 Chi-conotoxin peptides
02/01/2012EP2412716A1 Partial and full agonists of A1 adenosine receptors
02/01/2012EP2412711A1 Indazolepropionic acid amide compound
02/01/2012EP2412705A1 Novel therapeutic agent for cognitive impairment
02/01/2012EP2412381A1 Use of G-CSF for treating strokes
02/01/2012EP2411028A1 Therapy for promoting cell growth
02/01/2012EP2411020A2 Compositions and methods for treatment of hemorrhage
02/01/2012EP2411005A1 Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
02/01/2012EP2218459B1 Sustained release composition containing sdf-1
02/01/2012EP2107907B1 Combination of pemirolast and ramatroban for use in the treatment of inflammatory disorders
02/01/2012EP2064204B1 Inhibitors of 5 -lipoxygenase activating protein ( flap)
02/01/2012EP2062576B1 Adhesive preparation comprising desglymidodrine
1 ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 ... 1595